Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis

AimThe Gustave Roussy Immune Score (GRIm-Score) was originally designed to select cancer patients for immunotherapy, and later was reported to be a novel prognostic scoring system in lung cancer and esophageal cancer. This study was aimed to determine the prognostic role and predictive performance o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shan Tian, Yinghao Cao, Yanran Duan, Qi Liu, Pailan Peng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f277f435411843cf9e70c5231ff2c6bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f277f435411843cf9e70c5231ff2c6bc
record_format dspace
spelling oai:doaj.org-article:f277f435411843cf9e70c5231ff2c6bc2021-12-01T15:23:39ZGustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis2234-943X10.3389/fonc.2021.737283https://doaj.org/article/f277f435411843cf9e70c5231ff2c6bc2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.737283/fullhttps://doaj.org/toc/2234-943XAimThe Gustave Roussy Immune Score (GRIm-Score) was originally designed to select cancer patients for immunotherapy, and later was reported to be a novel prognostic scoring system in lung cancer and esophageal cancer. This study was aimed to determine the prognostic role and predictive performance of GRIm-Score in colorectal cancer (CRC) CRC patients.MethodsWe conducted a single-institution study of 1,579 adult CRC patients receiving surgical removal, and those patients were divided into low GRIm-Score group (scores 0, 1) and high GRIm-Score group (scores 2, 3). Propensity score matching (PSM) was executed to balance the potential confounding factors between the two groups. Survival and time-dependent receiver operating characteristic (Td-ROC) analyses were applied to depict the prognostic role and predictive significance of GRIm-Score in CRC patients.ResultsThere were 200 cases CRC patients in high GRIm-Score group and 1,379 cases in low GRIm-Score group. CRC patients with high GRIm-Score correspond with higher level of CEA, CA125, and inflammatory indexes, such as NLR, PLR, SII, PNI, and ALRI. Correlation analysis exhibited that GRIm-Score correlated well with the established inflammatory indexes. Survival analysis revealed that CRC patients in high GRIm-Score group showed worse overall survival (OS, P <0.0001) and disease-free survival (DFS, P <0.0001) compared with those in low GRIm-Score group. Results from multivariate Cox regression implicated that high GRIm-Score was not only a potent prognostic index for unfavorable OS (HR = 1.622, 95%CI: 1.118–2.355, P = 0.0109), but also a potent risk factor for worse DFS (HR = 1.743, 95%CI: 1.188–2.558, P = 0.0045). Td-ROC analysis demonstrated that GRIm-Score exhibited the superior discriminatory power in the prediction of OS and DFS when compared to SII, PNI, and ALRI. Such strong associations between high levels of preoperative GRIm-Score and unfavorable survival outcomes remained robust after PSM analysis.ConclusionGRIm-Score, a novel inflammatory and nutritional risk scoring system, is a potent prognostic index in CRC patients receiving surgical removal. GRIm-Score can be used as an effective and simplified risk stratification tool for postoperative survival prediction of CRC patients.Shan TianYinghao CaoYanran DuanQi LiuPailan PengFrontiers Media S.A.articlecolorectal cancerGustave Roussy Immune Scoresurvival analysispredictive valuepropensity score matchingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic colorectal cancer
Gustave Roussy Immune Score
survival analysis
predictive value
propensity score matching
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle colorectal cancer
Gustave Roussy Immune Score
survival analysis
predictive value
propensity score matching
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Shan Tian
Yinghao Cao
Yanran Duan
Qi Liu
Pailan Peng
Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
description AimThe Gustave Roussy Immune Score (GRIm-Score) was originally designed to select cancer patients for immunotherapy, and later was reported to be a novel prognostic scoring system in lung cancer and esophageal cancer. This study was aimed to determine the prognostic role and predictive performance of GRIm-Score in colorectal cancer (CRC) CRC patients.MethodsWe conducted a single-institution study of 1,579 adult CRC patients receiving surgical removal, and those patients were divided into low GRIm-Score group (scores 0, 1) and high GRIm-Score group (scores 2, 3). Propensity score matching (PSM) was executed to balance the potential confounding factors between the two groups. Survival and time-dependent receiver operating characteristic (Td-ROC) analyses were applied to depict the prognostic role and predictive significance of GRIm-Score in CRC patients.ResultsThere were 200 cases CRC patients in high GRIm-Score group and 1,379 cases in low GRIm-Score group. CRC patients with high GRIm-Score correspond with higher level of CEA, CA125, and inflammatory indexes, such as NLR, PLR, SII, PNI, and ALRI. Correlation analysis exhibited that GRIm-Score correlated well with the established inflammatory indexes. Survival analysis revealed that CRC patients in high GRIm-Score group showed worse overall survival (OS, P <0.0001) and disease-free survival (DFS, P <0.0001) compared with those in low GRIm-Score group. Results from multivariate Cox regression implicated that high GRIm-Score was not only a potent prognostic index for unfavorable OS (HR = 1.622, 95%CI: 1.118–2.355, P = 0.0109), but also a potent risk factor for worse DFS (HR = 1.743, 95%CI: 1.188–2.558, P = 0.0045). Td-ROC analysis demonstrated that GRIm-Score exhibited the superior discriminatory power in the prediction of OS and DFS when compared to SII, PNI, and ALRI. Such strong associations between high levels of preoperative GRIm-Score and unfavorable survival outcomes remained robust after PSM analysis.ConclusionGRIm-Score, a novel inflammatory and nutritional risk scoring system, is a potent prognostic index in CRC patients receiving surgical removal. GRIm-Score can be used as an effective and simplified risk stratification tool for postoperative survival prediction of CRC patients.
format article
author Shan Tian
Yinghao Cao
Yanran Duan
Qi Liu
Pailan Peng
author_facet Shan Tian
Yinghao Cao
Yanran Duan
Qi Liu
Pailan Peng
author_sort Shan Tian
title Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
title_short Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
title_full Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
title_fullStr Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
title_full_unstemmed Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
title_sort gustave roussy immune score as a novel prognostic scoring system for colorectal cancer patients: a propensity score matching analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f277f435411843cf9e70c5231ff2c6bc
work_keys_str_mv AT shantian gustaveroussyimmunescoreasanovelprognosticscoringsystemforcolorectalcancerpatientsapropensityscorematchinganalysis
AT yinghaocao gustaveroussyimmunescoreasanovelprognosticscoringsystemforcolorectalcancerpatientsapropensityscorematchinganalysis
AT yanranduan gustaveroussyimmunescoreasanovelprognosticscoringsystemforcolorectalcancerpatientsapropensityscorematchinganalysis
AT qiliu gustaveroussyimmunescoreasanovelprognosticscoringsystemforcolorectalcancerpatientsapropensityscorematchinganalysis
AT pailanpeng gustaveroussyimmunescoreasanovelprognosticscoringsystemforcolorectalcancerpatientsapropensityscorematchinganalysis
_version_ 1718404848118923264